The June issue of DOTmed Business News is all about nuclear medicine and molecular imaging. I received a lot of compliments from people on the issue, and I think it was a nice lead-up to the SNMMI show in Vancouver that DOTmed reporter Carol Ko and I attended last week.

In the June issue of the magazine, we wrote about new radiopharmaceuticals like Amyvid being used to help diagnose Alzheimer's disease. We also wrote about new hybrid technologies in molecular imaging, like PET/MR.

Both of these stories are now online so please check them out.

Carol Ko also wrote about some interesting studies that were presented at SNMMI. One story in particular that I think is worth reading is a story she wrote on a new enzyme that could be the key to better prostate cancer screenings -- a hot topic issue as we all know.

Thanks so much for your compliments and please keep the suggestions coming.